First Financial Bank Trust Division reduced its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 0.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 248,410 shares of the company’s stock after selling 1,864 shares during the period. Procter & Gamble accounts for approximately 3.9% of First Financial Bank Trust Division’s investment portfolio, making the stock its 4th largest holding. First Financial Bank Trust Division’s holdings in Procter & Gamble were worth $41,646,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Itau Unibanco Holding S.A. bought a new position in Procter & Gamble in the second quarter valued at approximately $28,000. Fairway Wealth LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $29,000. RPg Family Wealth Advisory LLC bought a new stake in Procter & Gamble in the third quarter valued at about $33,000. Quest Partners LLC acquired a new position in Procter & Gamble in the second quarter valued at about $36,000. Finally, Fairfield Financial Advisors LTD acquired a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $44,000. Institutional investors own 65.77% of the company’s stock.
Insider Activity at Procter & Gamble
In related news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This represents a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the sale, the chief executive officer now owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 75,439 shares of company stock worth $13,317,460. Insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the previous year, the business earned $1.83 earnings per share. The business’s revenue was down .6% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.43%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s payout ratio is 69.31%.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on PG. Morgan Stanley boosted their target price on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a research report on Monday, October 21st. Evercore ISI upped their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. JPMorgan Chase & Co. boosted their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Finally, Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $180.45.
Get Our Latest Research Report on PG
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- What Investors Need to Know to Beat the Market
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- When to Sell a Stock for Profit or Loss
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- 3 Best Fintech Stocks for a Portfolio Boost
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.